Author Question: Which local anesthetic agent would be considered for use first due to its lower rate of adverse ... (Read 78 times)

DyllonKazuo · **on:** Jul 23, 2018

Which local anesthetic agent would be considered for use first due to its lower rate of adverse effects?

1. Tetracaine (Pontocaine)
2. Procaine (Novocain)
3. Lidocaine (Xylocaine)
4. Chloroprocaine (Nesacaine)

Question 2

The client receives filgrastim (Neupogen). He asks the nurse, That is such a funny name; where do you suppose it comes from? What is the best response by the nurse?

1. It comes from the interleukins it stimulates; this one stimulates neuocytes.
2. It comes from the blood cell it stimulates; this one stimulates neutrophils.
3. It comes from the stem cells it stimulates, such as filgrastims.
4. It is a complicated process; the drug companies are secretive about it.

Natalie4ever · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

3
Rationale 1: Tetracaine (Pontocaine) is classified as an ester, which has more side effects than an amide.
Rationale 2: Procaine (Novocain) is classified as an ester, which has more side effects than an amide.
Rationale 3: Lidocaine is classified as an amide, and amides produce fewer side effects than do esters.
Rationale 4: Chloroprocaine (Nesacaine) is classified as an ester, which has more side effects than an amide.
Global Rationale: All except lidocaine are classified as esters. Lidocaine is classified as an amide, and amides produce fewer side effects than do esters.

Answer to Question 2

2
Rationale 1: There aren't any interleukins named neuocytes.
Rationale 2: Colony-stimulating factors (CSFs) are named according to the types of blood cells that they stimulate. Granulocyte colony-stimulating factor (G-CSF) increases the production of neutrophils, the most common type of granulocyte.
Rationale 3: There aren't any stem cells named filgrastims.
Rationale 4: Naming of drugs is not a complicated process.
Global Rationale: Colony-stimulating factors (CSFs) are named according to the types of blood cells that they stimulate. Granulocyte colony-stimulating factor (G-CSF) increases the production of neutrophils, the most common type of granulocyte. There aren't any interleukins named neuocytes. There aren't any stem cells named filgrastims. Naming of drugs is not a complicated process.